|
 |
—
News |
February 17, 2004 |
Vimicro
Licenses MoSys' 1T-SRAM Embedded Memory
MoSys, Inc. (Nasdaq:MOSY), the industry's leading
provider of high density SoC embedded memory solutions and Vimicro
Corporation, a cutting-edge digital multimedia chip company, today
announced the licensing of MoSys' 1T-SRAM(R) embedded memory technology
to be incorporated into Vimicro's next-generation
|
|
|
 |
|
February 9, 2004 |
Vimicro
Joined MIPI Alliance as the Only Chinese Member
The Mobile Industry Processor Interface
(MIPI) Alliance, the industry initiative founded by ARM, Nokia,
STMicroelectronics and Texas Instruments to define and promote open
standards for interfaces to mobile application processors, recently
announced the entry of Vimicro as one of its 39 members
|
|
|
 |
|
January 15, 2004 |
Chip
Maker Breaks Market Domination
Chinese high-tech company Vimicro has broken
decades-long foreign dominance in the digital multimedia CPU chip
sector with the success of its Xingguang digital multimedia CPU
chip, marking a milestone in China's integrated circuit (IC) industry,
said a top government official.
|
|
|
 |
|
December
30, 2003 |
Chinese
Digital Multimedia Chips Holding World's Largest Market Share
Millions of digital multimedia chips have been
sold in international market and dominated some 40 percent of the
world's computer image input chip market. This was jointly declared
on December 28, 2003 in Beijing by the Electronic Products Administration
with China Ministry of Information Industry and Beijing Zhongguancun
Science Park Administration
|
|
|
 |
|
November
27, 2003 |
Beijing
leads Shanghai, Guangdong in IC development
Beijing was China's first city to develop IC
designs and has since formed a complete IC industrial chain including
microelectronics research, IC design, production, testing, and materials
and equipment research.
|
|
|
 |
|
May
16, 2003 |
VXP
At Frontline Against SARS
Vimicro's VXP video communication system has
been deployed at XiaoTangShan Hospital, Beijing's leading medical
facility fighting against SARS
|
|
|
 |
|
|